These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 15294968

  • 1. Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses.
    Kim AH, Dimitriou ID, Holland MC, Mastellos D, Mueller YM, Altman JD, Lambris JD, Katsikis PD.
    J Immunol; 2004 Aug 15; 173(4):2524-9. PubMed ID: 15294968
    [Abstract] [Full Text] [Related]

  • 2. Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche.
    Vadrevu SK, Chintala NK, Sharma SK, Sharma P, Cleveland C, Riediger L, Manne S, Fairlie DP, Gorczyca W, Almanza O, Karbowniczek M, Markiewski MM.
    Cancer Res; 2014 Jul 01; 74(13):3454-65. PubMed ID: 24786787
    [Abstract] [Full Text] [Related]

  • 3. The administration of oseltamivir results in reduced effector and memory CD8+ T cell responses to influenza and affects protective immunity.
    Marois I, Cloutier A, Garneau É, Lesur O, Richter MV.
    FASEB J; 2015 Mar 01; 29(3):973-87. PubMed ID: 25414485
    [Abstract] [Full Text] [Related]

  • 4. C5a receptor1 inhibition alleviates influenza virus-induced acute lung injury.
    Song N, Li P, Jiang Y, Sun H, Cui J, Zhao G, Li D, Guo Y, Chen Y, Gao J, Sun S, Zhou Y.
    Int Immunopharmacol; 2018 Jun 01; 59():12-20. PubMed ID: 29621732
    [Abstract] [Full Text] [Related]

  • 5. Emergence of CD8+ T cells expressing NK cell receptors in influenza A virus-infected mice.
    Kambayashi T, Assarsson E, Michaëlsson J, Berglund P, Diehl AD, Chambers BJ, Ljunggren HG.
    J Immunol; 2000 Nov 01; 165(9):4964-9. PubMed ID: 11046023
    [Abstract] [Full Text] [Related]

  • 6. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
    Moulton RA, Mashruwala MA, Smith AK, Lindsey DR, Wetsel RA, Haviland DL, Hunter RL, Jagannath C.
    J Leukoc Biol; 2007 Oct 01; 82(4):956-67. PubMed ID: 17675563
    [Abstract] [Full Text] [Related]

  • 7. Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV.
    Jiang Y, Zhao G, Song N, Li P, Chen Y, Guo Y, Li J, Du L, Jiang S, Guo R, Sun S, Zhou Y.
    Emerg Microbes Infect; 2018 Apr 24; 7(1):77. PubMed ID: 29691378
    [Abstract] [Full Text] [Related]

  • 8. Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections.
    Hogan RJ, Usherwood EJ, Zhong W, Roberts AA, Dutton RW, Harmsen AG, Woodland DL.
    J Immunol; 2001 Feb 01; 166(3):1813-22. PubMed ID: 11160228
    [Abstract] [Full Text] [Related]

  • 9. Complement regulates conventional DC-mediated NK-cell activation by inducing TGF-β1 in Gr-1+ myeloid cells.
    Qing X, Koo GC, Salmon JE.
    Eur J Immunol; 2012 Jul 01; 42(7):1723-34. PubMed ID: 22535677
    [Abstract] [Full Text] [Related]

  • 10. Expression of the DX5 antigen on CD8+ T cells is associated with activation and subsequent cell death or memory during influenza virus infection.
    Kambayashi T, Assarsson E, Chambers BJ, Ljunggren HG.
    Eur J Immunol; 2001 May 01; 31(5):1523-30. PubMed ID: 11465109
    [Abstract] [Full Text] [Related]

  • 11. Viral neuraminidase treatment of dendritic cells enhances antigen-specific CD8(+) T cell proliferation, but does not account for the CD4(+) T cell independence of the CD8(+) T cell response during influenza virus infection.
    Oh S, Belz GT, Eichelberger MC.
    Virology; 2001 Aug 01; 286(2):403-11. PubMed ID: 11485408
    [Abstract] [Full Text] [Related]

  • 12. Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasiveness.
    Nitta H, Murakami Y, Wada Y, Eto M, Baba H, Imamura T.
    Oncol Rep; 2014 Oct 01; 32(4):1715-9. PubMed ID: 25050844
    [Abstract] [Full Text] [Related]

  • 13. Lymphotoxin-alpha-deficient mice make delayed, but effective, T and B cell responses to influenza.
    Lund FE, Partida-Sánchez S, Lee BO, Kusser KL, Hartson L, Hogan RJ, Woodland DL, Randall TD.
    J Immunol; 2002 Nov 01; 169(9):5236-43. PubMed ID: 12391242
    [Abstract] [Full Text] [Related]

  • 14. Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8+ T Cell Function and Impaired Viral Clearance.
    Lupfer CR, Stokes KL, Kuriakose T, Kanneganti TD.
    J Virol; 2017 Sep 01; 91(17):. PubMed ID: 28615208
    [Abstract] [Full Text] [Related]

  • 15. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
    Altenburg AF, van de Sandt CE, van Trierum SE, De Gruyter HLM, van Run PRWA, Fouchier RAM, Roose K, Saelens X, Volz A, Sutter G, de Vries RD, Rimmelzwaan GF.
    J Virol; 2016 Nov 15; 90(22):10209-10219. PubMed ID: 27581985
    [Abstract] [Full Text] [Related]

  • 16. Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection.
    Bertram EM, Lau P, Watts TH.
    J Immunol; 2002 Apr 15; 168(8):3777-85. PubMed ID: 11937529
    [Abstract] [Full Text] [Related]

  • 17. Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity.
    La Gruta NL, Turner SJ, Doherty PC.
    J Immunol; 2004 May 01; 172(9):5553-60. PubMed ID: 15100298
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo.
    Dolfi DV, Duttagupta PA, Boesteanu AC, Mueller YM, Oliai CH, Borowski AB, Katsikis PD.
    J Immunol; 2011 Apr 15; 186(8):4599-608. PubMed ID: 21389258
    [Abstract] [Full Text] [Related]

  • 20. Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model.
    Atkinson SM, Nansen A, Usher PA, Sondergaard BC, Mackay CR, Friedrichsen B, Chang CC, Tang R, Skov S, Haase C, Hornum L.
    Autoimmunity; 2015 Apr 15; 48(7):460-70. PubMed ID: 25915570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.